However, primary-care doctors often rely on paper-and-pencil tests rather then biomarker tools to diagnose Alzheimer’s. As ...

A simple blood test, taken as ... Now 10 years on, there is hope. Scientists have shown that the build-up of amyloid in the brains of people with Alzheimer’s can be successfully cleared.

“There are things that we can do at all stages of our lives deliberately,” says Prof Schott. “It’s never too early to start ...

The genetics behind Alzheimer's disease and other forms of dementia is complex, and DNA testing kits like 23andme cannot tell the complete story about a person's risk of developing the condition.

LATE is a prevalent condition in late life and can contribute to memory loss and cognitive decline, according to report ...

It can help identify people at risk of Alzheimer's disease and screen for conditions ... level can influence the results. The MoCA test is a simple, in-office tool that can quickly determine if there ...

Alzheimer’s patients with cognitive decline undergo blood tests, looking at plasma bio-markers. Researchers say it could be a game changer in early diagnosis. Dr. Tharick Pascoal, a UPMC ...

“For every patient coming with cognitive or behavioural complaints, you’re going to want to know if it’s Alzheimer’s disease or not — especially because now there are treatments.” A ...

More than half have Alzheimer's, but everyone would need testing. "There's an enormous gulf between current service provision and what we need to do, to deliver disease modifying therapies," said ...

Alzheimer’s disease affects one in five women and one in ten men over ... often utilize advanced diagnostic methods such as PET scans and cerebrospinal fluid tests, there is a pressing need for ...

The article quotes Dr. Susan Kohlhaas, Director of Research at Alzheimer’s Research U.K.: “We estimate that unless there are drastic changes in how people access specialist diagnostic tests for ...